DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells (original) (raw)

Research ArticleDrug Discovery and Translational Medicine

, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

Log in using your username and password

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.